Literature DB >> 1826630

Photofrin uptake by murine macrophages.

M Korbelik1, G Krosl, D J Chaplin.   

Abstract

The uptake of Photofrin by murine peritoneal macrophages in vivo and in vitro was examined. Cellular Photofrin content was measured either by performing a fluorometric assay or by using 14C-labeled drug. For comparison, the uptake of Photofrin by murine SCCVII tumor cells (squamous cell carcinoma) was also examined under the same conditions. The data demonstrate that macrophages have a much greater capacity for Photofrin uptake than SCCVII tumor cells. Photofrin contents at 24 h after drug administration (25 mg/kg) measured 420 +/- 90 (SD), 74 +/- 15, and 15 +/- 2 ng/micrograms of cell protein for peritoneal macrophages, tumor-associated macrophages, and SCCVII tumor cells, respectively. Factors that modify macrophage activity also influence the uptake of the drug by macrophages. The results support the assumption that Photofrin uptake by macrophages is dominated by phagocytosis of highly aggregated components of the drug. In vivo accumulated Photofrin material in peritoneal macrophages, tumor-associated macrophages, and tumor cells has shown very similar in vitro clearance from all three cell types. Only 20-30% of Photofrin was lost from the cells during the initial 24 h, mainly between 1 and 4 h of clearance incubation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826630

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  The impact of macrophage-cancer cell interaction on the efficacy of photodynamic therapy.

Authors:  Mladen Korbelik; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2015-01-26       Impact factor: 3.982

Review 2.  Porphyrins as ligands for 64copper: background and trends.

Authors:  Edgar Aguilar-Ortíz; Amir R Jalilian; Miguel A Ávila-Rodríguez
Journal:  Medchemcomm       Date:  2018-08-17       Impact factor: 3.597

3.  Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-08-10       Impact factor: 3.631

Review 4.  Photodynamic therapy.

Authors:  T J Dougherty; C J Gomer; B W Henderson; G Jori; D Kessel; M Korbelik; J Moan; Q Peng
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

5.  Electric field-assisted delivery of photofrin to human breast carcinoma cells.

Authors:  Joanna Wezgowiec; Maria B Derylo; Justin Teissie; Julie Orio; Marie-Pierre Rols; Julita Kulbacka; Jolanta Saczko; Malgorzata Kotulska
Journal:  J Membr Biol       Date:  2013-04-02       Impact factor: 1.843

6.  Distribution of Photofrin between tumour cells and tumour associated macrophages.

Authors:  M Korbelik; G Krosl; P L Olive; D J Chaplin
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

7.  In vivo fluorescence kinetics and localisation of aluminum phthalocyanine disulphonate in an autologous tumour model.

Authors:  M J Witjes; O C Speelman; P G Nikkels; C A Nooren; J M Nauta; B van der Holt; H L van Leengoed; W M Star; J L Roodenburg
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.